Press release
Investigation announced for Investors in Immunomedics, Inc. (NASDAQ: IMMU) over potential Wrongdoing
An investigation on behalf of current long term investors in Immunomedics, Inc. (NASDAQ: IMMU) shares.
Investors who are current long term investors in Immunomedics, Inc. (NASDAQ: IMMU) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: IMMU stocks follows a lawsuit filed against Immunomedics, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: IMMU stocks, concerns whether certain Immunomedics directors are liable in connection with the allegations made in that lawsuit.
According to that complaint filed in the U.S. District Court for the District of New Jersey the plaintiff alleges that the defendants misled investors by failing to disclose that the Company's Morris Plains, New Jersey manufacturing facility had suffered a serious data integrity breach, and that the FDA found Immunomedics manipulated bioburden samples, misrepresented an integrity test procedure in the batch record, and backdated batch records, including the dates of analytical results.
Those who purchased shares of Immunomedics, Inc. (NASDAQ: IMMU) have certain options and should contact the Shareholders Foundation.
Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Investors in Immunomedics, Inc. (NASDAQ: IMMU) over potential Wrongdoing here
News-ID: 2122235 • Views: …
More Releases from Shareholders Foundation
Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE: …
An investor, who purchased shares of James Hardie Industries plc (NYSE: JHX), filed a lawsuit over alleged violations of Federal Securities Laws by James Hardie Industries plc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of James Hardie Industries plc (NYSE: JHX) have certain options and for certain investors are short and strict deadlines running. Deadline: December 23, 2025. NYSE: JHX investors should contact the Shareholders…
Investigation announced for Long-Term Investors in SelectQuote, Inc. (NYSE: SLQT …
An investigation on behalf of current long-term investors in shares of SelectQuote, Inc. (NYSE: SLQT) concerning potential breaches of fiduciary duties by certain directors and officers of SelectQuote, Inc. was announced.
Investors who are current long term investors in SelectQuote, Inc. (NYSE: SLQT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term…
Lawsuit filed for Investors who lost money with shares of MoonLake Immunotherape …
An investor, who purchased shares of MoonLake Immunotherapeutics (NASDAQ: MLTX), filed a lawsuit over alleged violations of Federal Securities Laws by MoonLake Immunotherapeutics in connection with certain allegedly false and misleading statements.
Investors who purchased a significant amount of shares of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, have certain options and for certain investors are short and strict deadlines running. Deadline: December 15, 2025. NASDAQ:…
Dow Inc. (NYSE: DOW) Investor Alert: Deadline in Lawsuit on October 28, 2025
A deadline is coming up on October 28, 2025 in the lawsuit filed for certain investors of Dow Inc. (NYSE: DOW) over alleged securities laws violations by Dow Inc.
Investors who purchased shares of Dow Inc. (NYSE: DOW) have certain options and there are strict and short deadlines running. Deadline: October 28, 2025. Dow Inc. (NYSE: DOW) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -…
More Releases for Immunomedics
Radioimmunotherapy Market Expected to Deliver Dynamic Progression until 2027| Cu …
The global Radioimmunotherapy Market report provides an estimated market growth of Oil Water Separator industry. An inclusive analysis of the global Radioimmunotherapy Market report incorporates different market dynamics such as market drivers, restraints, and opportunities in front of the industry. Additionally, the research report contains potential opportunities in the Radioimmunotherapy Market at the domestic and global levels.
The competitive profiling of the leading companies operating across the global regions is…
Antibody Drug Conjugate Market Swot Analysis by key players Roche, ImmunoGen, Im …
The Antibody Drug Conjugate Market has witnessed continuous growth in the last few years and is projected to grow even further during the forecast period of 2020-2026. The exploration provides a 360° view and insights, highlighting major outcomes of the industry. These insights help the business decision-makers to formulate better business plans and make informed decisions to improved profitability. In addition, the study helps venture or private players in understanding…
Antibody Drug Conjugate Market By Size, Trends and Industry Analysis 2026| Roche …
Latest Report On Antibody Drug Conjugate Market including Market Landscape, and Market size, Revenues by players, Revenues by regions, Average prices, Competitive landscape, market Dynamics and industry trends and developments during the forecast period.
The global Antibody Drug Conjugate market is broadly analyzed in this report that sheds light on critical aspects such as the vendor landscape, competitive strategies, market dynamics, and regional analysis. The report helps readers to clearly…
Cancer Immunotherapy Market Dynamics, Trends, Emerging Growth Factors and Foreca …
This market research report administers a broad view of the Cancer Immunotherapy market on a Global basis, presenting a forecast and statistics in terms of revenue during the forecast period. It covers an illustrative study with detailed segmentation, complete research and development history, latest news and press releases.
Get Sample Copy of this Report at https://bit.ly/2LK5m16
Additionally, it demonstrates the future aspects and portrays a sketch of the key players involved…
Immunomedics - Cancer Drugs Clinical Pipeline Insight
“Immunomedics - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Immunomedics. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “13” cancer drugs in clinical pipeline and majority of them are in preclinical phase.
The report includes all the relevant information with respect to development of cancer drugs…
Global Antiandrogen Market 2017 : Genentech, GlaxoSmithKline, Immunomedics
Global Antiandrogen Market 2016-2017
A market study based on the " Antiandrogen Market " across the globe, recently added to the repository of Market Research, is titled ‘Global Antiandrogen Market 2017’. The research report analyses the historical as well as present performance of the worldwide Antiandrogen industry, and makes predictions on the future status of Antiandrogen market on the basis of this analysis.
Get Free Sample Copy of Report Here : http://www.marketsnresearch.com/request-for-sample.html?repid=8546
Top…
